Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
29,444,831
-
Share change
-
+5,975,859
-
Total reported value
-
$853,165,934
-
Put/Call ratio
-
425%
-
Price per share
-
$28.97
-
Number of holders
-
233
-
Value change
-
+$173,876,343
-
Number of buys
-
99
-
Number of sells
-
98
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2025
As of 31 Dec 2025,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,444,831 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, CITIGROUP INC, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, UBS Group AG, WELLS FARGO & COMPANY/MN, STATE OF WISCONSIN INVESTMENT BOARD, and LPL Financial LLC.
This page lists
233
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.